These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415 [TBL] [Abstract][Full Text] [Related]
49. Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus. Javeri H; Arora R; Correa AM; Hofstetter WL; Lee JH; Liao Z; McAleer MF; Maru D; Bhutani MS; Swisher SG; Izzo JG; Ajani JA Cancer; 2008 Sep; 113(6):1302-8. PubMed ID: 18623381 [TBL] [Abstract][Full Text] [Related]
50. Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy. Hitt R; Ciruelos E; Amador ML; Benito A; Sanchez JJ; Ballestin C; Cortes-Funes H Eur J Cancer; 2005 Feb; 41(3):453-60. PubMed ID: 15691646 [TBL] [Abstract][Full Text] [Related]
51. Adjuvant chemotherapy with cisplatin, etoposide, fluorouracil and leucovorin for gastric carcinoma. Papadakou M; Xydakis E; Bonios M; Makropoulou E; Boukis C; Kakavoulis T; Karaliotas C; Panagos G J BUON; 2006; 11(3):285-9. PubMed ID: 17309151 [TBL] [Abstract][Full Text] [Related]
52. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
53. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer. Xi H; Baldus SE; Warnecke-Eberz U; Brabender J; Neiss S; Metzger R; Ling FC; Dienes HP; Bollschweiler E; Moenig S; Mueller RP; Hoelscher AH; Schneider PM Clin Cancer Res; 2005 Dec; 11(23):8341-7. PubMed ID: 16322294 [TBL] [Abstract][Full Text] [Related]
54. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089. Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627 [TBL] [Abstract][Full Text] [Related]
55. Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients. Westra JL; Schaapveld M; Hollema H; de Boer JP; Kraak MM; de Jong D; ter Elst A; Mulder NH; Buys CH; Hofstra RM; Plukker JT J Clin Oncol; 2005 Aug; 23(24):5635-43. PubMed ID: 16110022 [TBL] [Abstract][Full Text] [Related]
56. Significance of biological markers for predicting prognosis and selecting chemotherapy regimens of advanced gastric cancer patients between continuous infusion of 5-FU and a combination of 5-FU and cisplatin. Boku N; Ohtsu A; Yoshida S; Shirao K; Shimada Y; Hyodo I; Saito H; Miyata Y; Jpn J Clin Oncol; 2007 Apr; 37(4):275-81. PubMed ID: 17522103 [TBL] [Abstract][Full Text] [Related]
57. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation. Jhawer M; Coit D; Brennan M; Qin LX; Gonen M; Klimstra D; Tang L; Kelsen DP; Shah MA Am J Clin Oncol; 2009 Aug; 32(4):356-62. PubMed ID: 19381079 [TBL] [Abstract][Full Text] [Related]
58. [Primary non-Hodgkin's lymphoma of the paranasal sinuses: a report of 14 cases]. Su ZY; Zhang DS; Zhu MQ; Shi YX; Jiang WQ Ai Zheng; 2007 Aug; 26(8):919-22. PubMed ID: 17697560 [TBL] [Abstract][Full Text] [Related]
59. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial. Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363 [TBL] [Abstract][Full Text] [Related]
60. Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer. Licitra L; Locati LD; Cavina R; Garassino I; Mattavelli F; Pizzi N; Quattrone P; Valagussa P; Gianni L; Bonadonna G; Solero CL; Cantu G Ann Oncol; 2003 Mar; 14(3):367-72. PubMed ID: 12598339 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]